STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Weight loss drugs will be available to adults 65 and…
Recent health headlines from STAT News.

You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Weight loss drugs will be available to adults 65 and…

At a Cambridge bar on Saturday, I watched straight-seeming couples congregate by a television showing basketball,…

Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling…

Medicaid cuts and fraud crackdown trickle down to states, threatening people with disabilities.

“In South Asian households, a child's disability triggers a specific kind of family crisis,” writes child and…

Jesse Gabriel "has passed more food policy in three years than most legislators enact in their entire careers," says…

AI for children requires “randomized controlled trials measuring real developmental outcomes, not engagement metrics,”…

The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he…

"There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.

In a rare move, nonprofit organization Blood Cancer United announced Thursday it was buying the remaining supplies of…

Health Study highlights influence of socioeconomic status on children’s brain development Chronic stress and disrupted…

Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

Seniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The Readout

In 2025, Elizabeth Selvin and her colleagues published in Nature Medicine for free. In 2026, it cost them $12,850, she…

Long Covid hasn’t disappeared. It’s just gone underground, writes Steven Phillips.

Without easy access to leaders within a field or top-of-the-line lab equipment, principal investigators outside top…

They previously published an investigation into insurers’ reliance on NaviHealth to scrutinize these requests, which…

A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024

Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and…

“I know what I’m getting into”: Dawn Zuidgeest-Craft on starting medical residency at almost 73.

You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In Europe, two divergent paths are emerging…

“Legal protection for abortion does not mean equitable access for minors,” a pediatrics resident writes.

In this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and…

GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its…

In a report published on the first anniversary of the Bethesda Declaration, 71 staffers write that they feel NIH…

GSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of…

Want to stay on top of the science and politics driving biotech today? Gene therapies can now cure disease, but…

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…

There may be nearly 2 million Amish Americans by 2075. That has large public health implications.

“Ebola is an unforgiving enemy,” writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outbreak.

You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference…

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical…

RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news

The White House has used the program to reward companies that help its political goals.

The longevity festival known as Vitalist Bay challenges the stereotype of the movement being solely for the wealthy.…

An oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.

“One of the cancer community’s worst fears is coming to pass,” writes Gwen Nichols of Blood Cancer United.

Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys…

Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as…

The pope's encyclical on artificial intelligence addresses its implications for Catholic hospitals and the broader…

New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout

“Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on…

“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.

“Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine…

Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.

While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers…

A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop…

A new medical meal program in one state has shown promise in reducing healthcare costs. The initiative focuses on…

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data…
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.